These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21368898)

  • 1. Gene transfer to the rhesus monkey brain using SV40-derived vectors is durable and safe.
    Louboutin JP; Marusich E; Fisher-Perkins J; Dufour JP; Bunnell BA; Strayer DS
    Gene Ther; 2011 Jul; 18(7):682-91. PubMed ID: 21368898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors.
    Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele E; Strayer DS
    Gene Ther; 2007 Jun; 14(12):939-49. PubMed ID: 17443215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
    Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
    Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors.
    Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
    Gene Ther; 2007 Dec; 14(23):1650-61. PubMed ID: 17914406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors.
    Strayer DS; Pomerantz RJ; Yu M; Rosenzweig M; BouHamdan M; Yurasov S; Johnson RP; Goldstein H
    Gene Ther; 2000 May; 7(10):886-95. PubMed ID: 10845727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using gene delivery to protect HIV-susceptible CNS cells: inhibiting HIV replication in microglia.
    Cordelier P; Strayer DS
    Virus Res; 2006 Jun; 118(1-2):87-97. PubMed ID: 16414141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracisternal rSV40 administration provides effective pan-CNS transgene expression.
    Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
    Gene Ther; 2012 Jan; 19(1):114-8. PubMed ID: 21614027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 gp120-induced neuroinflammation: relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes.
    Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
    Exp Neurol; 2010 Jan; 221(1):231-45. PubMed ID: 19913017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat bone marrow progenitor cells transduced in situ by rSV40 vectors differentiate into multiple central nervous system cell lineages.
    Louboutin JP; Liu B; Reyes BA; Van Bockstaele EJ; Strayer DS
    Stem Cells; 2006 Dec; 24(12):2801-9. PubMed ID: 16960137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications.
    Agrawal L; Louboutin JP; Strayer DS
    Virology; 2007 Jul; 363(2):462-72. PubMed ID: 17336361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer to the cerebellum.
    Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
    Cerebellum; 2010 Dec; 9(4):587-97. PubMed ID: 20700772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
    Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
    Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow-derived cells migrate to line the vessels of the CNS: opportunities for gene delivery to CNS vasculature.
    Louboutin JP; Chekmasova AA; Reyes BA; Van Bockstaele EJ; Strayer DS
    Neuroscience; 2011 Nov; 195():215-23. PubMed ID: 21906658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivering genes to the organ-localized immune system: long-term results of direct intramarrow transduction.
    Louboutin JP; Liu B; Chekmasova AA; Reyes BA; van Bockstaele EJ; Strayer DS
    J Gene Med; 2007 Oct; 9(10):843-51. PubMed ID: 17694566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-brain barrier abnormalities caused by exposure to HIV-1 gp120--protection by gene delivery of antioxidant enzymes.
    Louboutin JP; Reyes BA; Agrawal L; Maxwell CR; Van Bockstaele EJ; Strayer DS
    Neurobiol Dis; 2010 May; 38(2):313-25. PubMed ID: 20219678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer.
    Zhang Y; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
    Mol Vis; 2003 Oct; 9():465-72. PubMed ID: 14551536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo gene transfer to the CNS using recombinant SV40-derived vectors.
    Louboutin JP; Agrawal L; Liu B; Strayer DS
    Expert Opin Biol Ther; 2008 Sep; 8(9):1319-35. PubMed ID: 18694352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy using SV40-derived vectors: what does the future hold?
    Strayer DS
    J Cell Physiol; 1999 Dec; 181(3):375-84. PubMed ID: 10528223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SV40-based gene therapy vectors: turning an adversary into a friend.
    Strayer DS
    Curr Opin Mol Ther; 2000 Oct; 2(5):570-8. PubMed ID: 11249759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant AAV-mediated gene delivery to the central nervous system.
    Tenenbaum L; Chtarto A; Lehtonen E; Velu T; Brotchi J; Levivier M
    J Gene Med; 2004 Feb; 6 Suppl 1():S212-22. PubMed ID: 14978764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.